Nie Q, Shen Y, Luo M, Sheng Z, Zhou R, Li G, et al. Analysis of sleep for the American population: result from NHANES database. J Affect Disord. 2024;347:134–43.
Di H, Guo Y, Daghlas I, Wang L, Liu G, Pan A, Adults US, et al. JAMA Netw Open. 2022;5:2017–20.
Mukherjee U, Sehar U, Brownell M, Reddy PH. Mechanisms, consequences and role of interventions for sleep deprivation: focus on mild cognitive impairment and Alzheimer’s disease in elderly. Ageing Res Rev. 2024;100:102457.
Liu P-L, Gao S, Zhang Y, Li J, Du J, Dong Q-L, et al. Associations between the triglyceride-glucose index and its combined indices with sleep disorders and the mediating role of depressive symptoms: results from two nationally representative population studies. J Affect Disord. 2025;386:119480.
Liu C, Qiu L, Wang T, Ye Z, Wu S, Li D, et al. Association between visceral adiposity index and sleep disorders among the U.S. adults: a cross-sectional study. Front Neurol. 2025;16:1540182.
Chen F, Niu Y, Wu R, Jiang H, Zhu J, Wang C, et al. Association between cardiometabolic index and cardiovascular disease: evidence from the NHANES 2007–2018. Front Cardiovasc Med. 2025;12:1516591.
Wang W, Du Z, Xie P. Constructing a predictive model to evaluate the risk of CHD based on new metabolic indicators. Vasc Health Risk Manag. 2025;21:371–82.
Huang B-H, Del Pozo Cruz B, Teixeira-Pinto A, Cistulli PA, Stamatakis E. Influence of poor sleep on cardiovascular disease-free life expectancy: a multi-resource-based population cohort study. BMC Med. 2023;21:75.
Lyons OD. Sleep disorders in chronic kidney disease. Nat Rev Nephrol. 2024;20:690–700.
Liu M, Heizhati M, Li N, Lin M, Gan L, Zhu Q, et al. The relationship between obstructive sleep apnea and risk of renal impairment in patients with hypertension, a longitudinal study. Sleep Med. 2023;109:18–24.
Zhang Y, Zhong Z, Tang Z, Wang R, Wu J, Na N, et al. Insomnia and sleep duration for kidney function: Mendelian randomization study. Ren Fail. 2024;46:2387430.
Wakabayashi I, Daimon T. The cardiometabolic index as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin Chim Acta. 2015;438:274–8.
Xiao Y, Tang B, Wang J, Cai Z, An H, Tao N. Study of the interaction between cardiometabolic index and inflammatory index on the risk of prostate cancer development. Front Immunol. 2025;16:1591879.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461–70.
Mavraganis G, Georgiopoulos G, Zervas G, Aivalioti E, Delialis D, Petropoulos I, et al. Circulating amyloid beta 1–40 peptide as an associate of renal function decline. Eur J Clin Invest. 2025;55:e70006.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–13.
Giannos P, Prokopidis K, Candow DG, Forbes SC, Celoch K, Isanejad M, et al. Shorter sleep duration is associated with greater visceral fat mass in US adults: findings from NHANES, 2011–2014. Sleep Med. 2023;105:78–84.
Xu C, Zhao S, Yu S, Tang J, Zhang H, Xu B, et al. Short sleep duration was associated with increased regional body fat in US adults: the NHANES from 2011 to 2018. Nutrients. 2022;14:2840.
Zhong Y, Li Y, Zhong M, Peng C, Zhang H, Tian K. Association between waist circumference and sleep disorder in the elderly: based on the NHANES 2005–2018. PLoS ONE. 2024;19:e0308860.
Prakaschandra DR, Naidoo DP. The association of cardiometabolic disorders with sleep duration: a cross-sectional study. Afr Health Sci. 2022;22:273–83.
Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32:1484–92.
Cash RE, Beverly Hery CM, Panchal AR, Bower JK. Association between sleep duration and ideal cardiovascular health among US Adults, National health and nutrition examination Survey, 2013–2016. Prev Chronic Dis. 2020;17:E43.
Li J, Covassin N, Bock JM, Mohamed EA, Pappoppula LP, Shafi C, et al. Excessive daytime sleepiness and cardiovascular mortality in US adults: A NHANES 2005–2008 Follow-Up study. Nat Sci Sleep. 2021;13:1049–59.
Gao J, Shi L, Zhu X, Liu J. Association of obstructive sleep apnea with cardiometabolic diseases and cardiovascular mortality. Clin Respir J. 2023;8:764–770.
Strenth C, Wani A, Alla R, Khan S, Schneider FD, Thakur B. Obstructive sleep apnea and its cardiac implications in the United States: an age-stratified analysis between young and older adults. J Am Heart Assoc. 2024;13:e033810.
Lundberg TR, Tryfonos A, Eriksson LMJ, Rundqvist H, Rullman E, Holmberg M, et al. Longitudinal changes in regional fat and muscle composition and cardiometabolic biomarkers over 5 years of hormone therapy in transgender individuals. J Intern Med. 2025;297:156–72.
Karras SN, Michalakis K, Katsiki N, Kypraiou M, Vlastos A, Anemoulis M, et al. Interrelations of leptin and Interleukin-6 in vitamin D deficient and overweight orthodox nuns from Northern greece: A pilot study. Nutrients. 2025;17:1144.
Gan X, He P, Ye Z, Zhou C, Liu M, Yang S, et al. Adherence to a healthy sleep pattern and new-onset acute kidney injury. Sleep Health. 2023;9:977–83.
Geng T, Li X, Ma H, Heianza Y, Qi L. Adherence to a healthy sleep pattern and risk of chronic kidney disease: the UK biobank study. Mayo Clin Proc. 2022;97:68–77.
Li J, Huang Z, Hou J, Sawyer AM, Wu Z, Cai J, et al. Sleep and CKD in Chinese adults: a cross-sectional study. Clin J Am Soc Nephrol. 2017;12:885.
Abu Kar S, Harris RC. Chronic kidney disease and sex dimorphism. Curr Opin Nephrol Hypertens. 2025;34:314–21.
Park Y. Analysis of the relationship between components of metabolic syndrome and estimated glomerular filtration rate (eGFR). Heliyon. 2025;11:e42591.
Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126:1549–64.
Irwin MR. Sleep and inflammation: partners in sickness and in health. Nat Rev Immunol. 2019;19:702–15.
Després J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–7.
Koren D, Taveras EM. Association of sleep disturbances with obesity, insulin resistance and the metabolic syndrome. Metabolism. 2018;84:67–75.
Al-Shama RFM, Uleman JF, Pereira M, Claassen JAHR, Dresler M. Cerebral blood flow in sleep: a systematic review and meta-analysis. Sleep Med Rev. 2024;77:101977.
de Donato A, Buonincontri V, Borriello G, Martinelli G, Mone P. The dopamine system: insights between kidney and brain. Kidney Blood Press Res. 2022;47:493–505.
Jabbari B, Vaziri ND. The nature, consequences, and management of neurological disorders in chronic kidney disease. Hemodial Int. 2018;22:150–60.
Mazumder MK, Paul R, Bhattacharya P, Borah A. Neurological sequel of chronic kidney disease: from diminished acetylcholinesterase activity to mitochondrial dysfunctions, oxidative stress and inflammation in mice brain. Sci Rep. 2019;9:3097.
Ma X, Zhang Y, Ma S, Li P, Ding D, Liu H, et al. Association between abnormal thalamic metabolites and sleep disturbance in patients with end-stage renal disease. Metab Brain Dis. 2018;33:1641–8.
Wang H-Y, Shi W-R, Yi X, Wang S-Z, Luan S-Y, Sun Y-X. Value of reduced glomerular filtration rate assessment with cardiometabolic index: insights from a population-based Chinese cohort. BMC Nephrol. 2018;19:294.